期刊文献+

福辛普利和氯沙坦对SHR血管紧张素Ⅱ受体1基因表达的影响 被引量:2

The Influence of Fosinpril and Losartan on Angiotensin Ⅱ Receptor 1 Gene Expression in SHR
暂未订购
导出
摘要 目的 研究福辛普利和氯沙坦对自发性高血压大鼠 (SHR)血管紧张素Ⅱ受体 1(AT1 R)的基因表达水平及心血管细胞增殖的影响 ,探讨高血压病的病理机制。方法  48只 10周龄SHR随机分 3组 ,1组 :服福辛普利 5mg·kg-1·d-1;2组 :服氯沙坦 2 0mg·kg-1·d-1;3组 (对照组 ) :服安慰剂。 3组分别灌胃持续 9周 ,实验前及实验中每 2周测尾动脉血压 ,9周后 ,抽血并处死动物取材 ,放免法测血管紧张素Ⅱ (AngⅡ ) ,用半定量RT PCR测量心肌AT1 R的mRNA水平 ,光、电镜观察心肌及主动脉组织学改变。 结果 血压 :对照组随增龄上升 ,两治疗组实验第 2周起各次均较治疗前低 ,差异多具显著性 ,实验第 8周福辛普利组为 (16 5 .1± 4 9)mmHg、氯沙坦组为 (15 6 3± 4 2 )mmHg ,均较对照组 (179 1± 10 4 )mmHg低 ,差异显著 ,P <0 0 1。血浆AngⅡ浓度 :对照组为 (4 40 0± 190 3) pg/mL ,福辛普利组为 (5 6 6 0± 149 3) pg/mL和氯沙坦组 (5 2 9 3± 2 0 0 9)pg/mL均较对照组高 ,但均无显著性差异 ,P >0 0 5。心肌AT1 R的mRNA水平 :福辛普利组为 (72 0± 35 0 ) %,对照组为 (10 2 4± 2 1 9) %,显著高于前者 ,P <0 0 5 ;氯沙坦组为 (10 1 9± 2 7 3) %,与对照组差异无显著性 ,P >0 0 5 ,但较福辛普利组高 。 Objective To study the effect of fosinpril(Fos) and losartan(Los) on angiotensin Ⅱ receptor1(AT 1-R) gene expression in myocardium in SHR. Methods Forty-eight 10 wk old SHR were divided randomly into 3 groups:Fos treated group(5 mg·kg -1·d -1);Los treated group(20 mg·kg -1·d -1),and control. Medications were fed through gastric gavage for 9 wks. BP was measured using tail-cuff methods every 2 wks. After 9 wks treatment,blood and total RNA were extracted from the myocardium of SHR. Plasma Ang Ⅱ were measured with radioimmunoassay. The mRNA of myocardium AT 1-R were measured with RT-PCR. Histology study of the mycardium and aorta was examined using light microscope and electromicroscope. Results Fos and Los decreased BP significantly from 2nd wk of treatment. At the 8th wk,BP in Fos group was 165±5 mmHg,Los group was 179±10 mmHg,and control group was 179±10 mmHg. No difference of plasma AngⅡ level was found among the 3 groups. The mRNA level of myocardium AT 1-R was (72±35)% in Fos group,(102±27)% in Los group and (102±21)% in control. mRNA of AT 1-R was signficantly lower in Fos group than that in control(P<0.05) with little difference between Los group and control. Both Fos and Los treatment significantly alleviated cardiovascular cell hypertrophy with better effects found in Los. Conclusion The gene expression of myocardium AT 1-R in SHR was attenuated by Fos but not by Los. Although both of them inhibited the development of cardiovascular hypertrophy.
出处 《高血压杂志》 CSCD 2002年第4期356-361,共6页 Chinese Journal of Hypertension
基金 深圳市三项科技经费资助 (编号 :19980 5 0 4)
关键词 福辛普利 氯沙坦 SHR 血管紧张素Ⅱ受体 基因表达 自发性高血压 fosinpril losartan SHR angiotensin Ⅱ receptor gene expression
  • 相关文献

参考文献12

  • 1[1]Aceto JF, Baker KM. Angiotensin Ⅱ receptor-midiated stimulation of protein synthesis in chick heart cell[J]. Am J Physiol,1990,258:H806-H813.
  • 2[2]Ibrahim J, Hughes AD, Sever PD. Action of angiotesin Ⅱ on DNA synthesis by human saphenous vein in organ culture[J]. Hypertens,2000,36(5):917-921.
  • 3[3]Griffin SA, Brown WCB, MacPherson F, et al. Angiotensin Ⅱ causes vascular hypertrophy in part by a non-pressor mechanism[J]. Hypertens,1991,17:626-635.
  • 4[4]Su EJ, Lombardi DM, Siegal J, et al. Angiotensin Ⅱ induces vascular smooth muscle cell replication independent of blood pressure[J]. Hypertens,1998,31:1331-1337.
  • 5[5]Junichi Suzuki, Hiroaki Matsubara, Masaya Urakami, et al. Rat angiotensinⅡ(Type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy[J]. Circulation Research, 1993,73(3):439-447.
  • 6[6]Viseslav D, Sim K, George B. Angiotensin receptor blocker use for hypertension treatment in the elderly[J]. Annals of Long-Term care ,1999,7(8):305-308.
  • 7[7]VanKats JP, Duncker DJ, Haitsma DB, et al.Angiotensin-converting enzyme inhibition and angiotensin Ⅱ type 1 receptor blockade prevent cardiac remodeling in pig after myocardial infarction:role of tissue angiotensinⅡ[J]. Circulation,2000,26(9):1556-1563.
  • 8[8]Yayama K, Wang C, Chao L,et al. Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in goldblatt hypertensive rat[J]. Hypertens,1998,31:1104-1110.
  • 9[9]Dzau VJ,Re R. Tissue angiotensin system in cardiovascular medicine :a paradigm shift?[J].Circulation,1994,89:493-498.
  • 10[10]Nunez E,Hosoya K,Susic D,et al.Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR[J].Hypertens,1997,29:519-524.

同被引文献10

  • 1[4]Adams MA,Trudeau L Irbesartan: review of pharmacology and comparative properties.Can J Clin Pharmacol 2000;7(1):22
  • 2Koh N, Fujimori Y, Nishiguchi S, et al. Severely reduced production of klotho in human chronic renal failure kidney [J]. Biochem Biophys Res Commun, 2001, 280(4): 1015- 1020.
  • 3Miyamoto K, Ito M, Segawa H, etal. Molecular targets of hyperphosphataemia in chronic renal failure[ J]. Nephrol Dial Transplant, 2003, 18(suppl 3) : iii79-80.
  • 4Mitani H, Ishizaka N, Aizawa T, et al. In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage[ J]. Hypertension, 2002, 39(4): 838-843.
  • 5Hamdi H K, Castellon R. A genetic variant of ACE increases cell survival: a new paradigm for biology and disease [ J ]. Biochem Biophys Res Commun, 2004, 318(1): 187-191.
  • 6Yang J, Matsukawa N, Rakugi H, et al. Upregulation of cAMP is a new functional signal pathway of klotho in endothelial cells [ J]. Biochem Biophys Res Commun, 2003, 301 (2) : 424-429.
  • 7Sugiura H, Yoshida T, Tsuchiya K, et al. Klotho reduces apoptosis in experimental ischaemic acute renal failure [ J]. Nephrol Dial Transplant, 2005, 20(12): 2636-2645.
  • 8Haruna Y, Kashihara N, Satoh M, et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene[J]. PNAS, 2007, 104(7): 2331-2336.
  • 9周巧玲,林书典,彭卫生,敖翔,武蓉,成小苗,汤天凤.缬沙坦对血管紧张素Ⅱ抑制klotho基因表达的影响[J].肾脏病与透析肾移植杂志,2007,16(4):336-339. 被引量:13
  • 10黄高忠,杜荣增,吴宗贵,陈凌.国产厄贝沙坦片治疗原发性高血压的随机双盲临床试验[J].高血压杂志,2002,10(1):61-63. 被引量:11

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部